An orthotopic skull base model of malignant meningioma

Brain Pathology

Volumn 18, Issue 2, 2008, Pages 172-179

  Baia, Gilson S ^a   Dinca, Eduard B ^a   Ozawa, Tomoko ^a   Kimura, Edna T ^b   McDermott, Michael W ^a   James, C David ^a   VandenBerg, Scott R ^a   Lal, Anita ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioluminescent imaging; IOMM Lee; Meningioma; Orthotopic; Skull base; Xenografts

Indexed keywords

MATRIGEL; TEMOZOLOMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BRAIN HYPOXIA; BRAIN TISSUE; CANCER CELL CULTURE; CELL DEATH; CELL DENSITY; CELL LOSS; CONTROLLED STUDY; DURA MATER; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALIGNANT MENINGIOMA; MITOSIS; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; SKULL BASE; SURVIVAL TIME; TUMOR GROWTH; TUMOR LOCALIZATION; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; DACARBAZINE; DISEASE MODELS, ANIMAL; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; MENINGEAL NEOPLASMS; MENINGIOMA; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SKULL BASE NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 41149178776     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2007.00109.x     Document Type: Article

References (28)

1. Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, Vandenberg SR et al (2006) A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol 78 : 113 121.
2. Bello MJ, Aminoso C, Lopez-Marin I, Arjona D, Gonzalez-Gomez P, Alonso ME et al (2004) DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol (Berl) 108 : 413 421.
3. Burger PC, Scheithauer BW, Vogel FS (2002) Surgical Pathology of the Nervous System and Its Coverings, 4th edn. Churchill Livingstone : New York.
4. Cankovic M, Mikkelsen T, Rosenblum ML, Zarbo RJ (2007) A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue. Lab Invest 87 : 392 397.
5. Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS (2007) Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery 60 : 750 759 discussion 759 760.
6. Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Berger MS, James CD (2007) Bioluminescence monitoring of intracranial gliolastoma xenograft response to primary and salvage temozolomide therapy. J Neurosurg 107 : 610 616.
7. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59 : 793 797.
8. Friedman HS, Kerby T, Calvert H (2000) Temozolomide and treatment of malignant glioma. Clin Cancer Res 6 : 2585 2597.
9. Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW (2006) Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Clin Cancer Res 12 : 1868 1875.
10. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352 : 997 1003.
11. Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A et al (2002) Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 16 : 1060 1065.
12. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53 : 457 481.
13. Lee WH (1990) Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27 : 389 395.
14. Lee WH, Tu YC, Liu MY (1988) Primary intraosseous malignant meningioma of the skull: case report. Neurosurgery 23 : 505 508.
15. Mathiesen T, Lindquist C, Kihlstrom L, Karlsson B (1996) Recurrence of cranial base meningiomas. Neurosurgery 39 : 2 7.
16. McCutcheon IE, Friend KE, Gerdes TM, Zhang BM, Wildrick DM, Fuller GN (2000) Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth. J Neurosurg 92 : 306 314.
17. Mendenhall WM, Morris CG, Amdur RJ, Foote KD, Friedman WA (2003) Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 98 : 1473 1482.
18. Modha A, Gutin PH (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57 : 538 550.
19. Peto R, Peto J (1972) Asymptotically efficient rank invariant procedures. J R Stat Soc Ser A Stat Soc 135 : 185 207.
20. Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH, Paulus W (2005) Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 85 : 1163 1171.
21. Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2006) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109 : 588 597.
22. Riemenschneider MJ, Perry A, Reifenberger G (2006) Histological classification and molecular genetics of meningiomas. Lancet Neurol 5 : 1045 1054.
23. Robb VA, Li W, Gutmann DH (2004) Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression. Oncogene 23 : 3589 3596.
24. Salhia B, Rutka JT, Lingwood C, Nutikka A, Van Furth WR (2002) The treatment of malignant meningioma with verotoxin. Neoplasia 4 : 304 311.
25. Schrell UM, Rittig MG, Anders M, Kiesewetter F, Marschalek R, Koch UH, Fahlbusch R (1997) Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86 : 845 852.
26. Surace EI, Lusis E, Haipek CA, Gutmann DH (2004) Functional significance of S6K overexpression in meningioma progression. Ann Neurol 56 : 295 298.
27. van Furth WR, Laughlin S, Taylor MD, Salhia B, Mainprize T, Henkelman M et al (2003) Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system. Can J Neurol Sci 30 : 326 332.
28. Yoo H, Baia GS, Smith JS, McDermott MW, Bollen AW, Vandenberg SR et al (2007) Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas. Clin Cancer Res 13 : 68 75.